Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA).

Download IPO Stocks on Google Play Download IPO Stocks on the App Store

Equity Overview

Price & Market Data

Price: $10.04

Daily Change: $0.00 / 0.00%

Range: $0 - $0

Market Cap: $336,511,680

Volume: 0

Performance Metrics

1 Week: 0.05%

1 Month: 0.20%

3 Months: 0.60%

6 Months: 0.60%

1 Year: 0.60%

YTD: 0.80%

Company Details

Employees: 2

Sector: Finance

Industry: Financial conglomerates

Country:

Details

Drugs Made In America Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses in the pharmaceutical industry. The company was incorporated in 2024 and is based in Fort Lauderdale, Florida.

Selected stocks

Mountain Lake Acquisition Corp. (MLACU)

FG Merger II Corp. (FGMCU)

Fifth Era Acquisition Corp I (FERA)